Inovent Granted Extension to Complete Qualifying Transaction

inoVent

NEWS RELEASE

Inovent Granted Extension to Complete Qualifying Transaction

Vancouver, British Columbia, April 29, 2016 - Inovent Capital Inc. (TSX Venture - IVQ.P, "Inovent” or the “Company") is pleased to report that the TSX Venture Exchange (the “Exchange”) has accepted the Company’s application for an extension to complete a Qualifying Transaction (“QT”). Inovent will have until September 21, 2016 to complete a QT or complete a financing, satisfactory to the Exchange, which will facilitate the Company making a further extension request.

Prior to September 21, 2016, the Company is required to complete a QT with this requirement being satisfied by the Exchange issuing a Final Exchange Bulletin that evidences final Exchange Acceptance and the closing of the QT. If this requirement is not met, then the Company’s shares will be transferred to NEX.

Regarding the Company’s trading status, reinstatement to trading can occur either when the Company completes its QT in accordance with Exchange Policy 2.4 or upon application for reinstatement, satisfactory to the Exchange, at the time of its transfer to NEX.

Should the Company not complete a QT or file the required documentation to be transferred to NEX prior to September 21, 2016, then the shares of the Company will be delisted.

On behalf of the board of Inovent:

INOVENT CAPITAL INC.

Per: “David Brett”

David H. Brett, MBA Chief Executive Officer & Director

For more information, please contact:

David Brett Chief Executive Officer Tel. 604-682-2421 [email protected] www.inoventcapital.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.